Regenerative medicine program set for Thursday in Vail |

Regenerative medicine program set for Thursday in Vail

Dr. Chris Centeno treats a knee injury non-surgically with the patient’s own stem cells and blood platelets. Fluoroscopy (the machine you see on either side of the knee) allows the doctor to see exactly where the cells are placed during the procedure. This machine is like a live X-ray, allowing the doctor to see both the needle and the cells being dispersed.
Special to the Daily |

If You Go

What: Vail Symposium. The Patient Consumer: Navigating the Waters of Regenerative Medicine

When: Thursday, Jan. 8. 5:30 p.m. reception, 6 p.m. presentation

Where: Vail Mountain School

Tickets: $25 in advance, $35 at the door, $10 students, teachers and VVYPA members

Information: or call 970-476-0954

VAIL — Regenerative medicine, including stem cells, seems miraculous, so of course the demand far outstrips the pace at which research can create a supply.

“The medical and scientific community are doing everything they can, but the demand for them always outpaces their availability. Research take a long time,” said Dr. David Karli with the Steadman Clinic.

The Vail Symposium is gathering three experts in the field to discuss what’s available, what the limitations are, and what’s in the pipeline. The program, “The Patient Consumer: Navigating the Waters of Regenerative Medicine,” takes place Thursday at Vail Mountain School. Along with Karli, Dr. Chris Centeno and Dr. Maynard Howe also are on the panel.


The Vail Symposium had its first stem cell program last year, outlining the progress of stem cell science, said the Symposium’s Dale Mosier. It was so fascinationg they decided to do one every year, Mosier said.

“This year’s presenters have been doing stem cell/regenerative medicine for many years and they have the successful history in different applications many patients to make for an outstanding panel,” Mosier said.

Thursday’s panel will be moderated by Rohn Robbins.

What is it?

Regenerative medicine is anything that would facilitate regenerative healing in the body, Karli said.

It works best for body parts that don’t heal well on their own because they lack a good blood supply. If you pull a muscle, it heals because blood carries healing properties to the injury, Karli explained.

However, cartilage does not enjoy that sort of blood flow, so leaving it to heal on its own is problematic.

That can mean surgery, or maybe regenerative medicine — stem cells — or both.

“It has had pretty strong outcomes. It’s safe, based on data and anecdotally,” Karli said.

Karli is among the first to launch a new bone marrow-derived stem cell injection program for patients with arthritic conditions and chronic soft tissue disorder of muscle, tendon and ligament.

Karli has been at this for about six years, focusing on things like arthritis treatments and helping along the healing process for surgical patients.

At the Steadman Clinic, adult stem cells are taken from the patient’s own tissue. They’re not developing stem cells in a lab, and it’s not the embryonic stem cell research that created a political upheaval a few years ago.

“If we’re treating you, we’re taking cells from you. We take them out of you, concentrate them, put them back in and let them do their thing,” Karli said.

Karli will be joined by Dr. Chris Centeno and Dr. Maynard Howe for Thursday’s program.

Centeno is CEO of Regenerative Sciences. His medical group operates the world’s largest and oldest stem cell treatment registry focused in the field of orthopedic and musculoskeletal injuries. His clinical practice in Colorado (The Centeno-Schultz Clinic in Broomfield) has a state-of-the-art cell biology research lab, a bioengineering department and a clinical research arm.

Centeno will discuss the broad range of possibilities stem cells may take over the long term.

Howe is CEO and vice chairman of Stemedica Cell Technologies, the world’s leading developer, manufacturer and distributor of allogeneic stem cell technology, which recently received an IND approval from the FDA to initiate stem cell clinical research in the United States for several neurological trials.

Howe will talk about the products available for a specific line of adult stem cells, their successes and future expectations. He will also share an international perspective on the progress and issues facing stem cells.

Howe and Stemedica have been in the news lately for the treatment of hockey great Gordie Howe (no relation).

Staff Writer Randy Wyrick can be reached at 970-748-2935 or

Support Local Journalism